Medicinal Products Supply

Dáil Éireann Debate, Thursday - 25 May 2017

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Thursday, 25 May 2017

Ceisteanna (198)

Mary Butler

Ceist:

198. Deputy Mary Butler asked the Minister for Health his plans to address the situation whereby persons who were receiving Respreeza for alpha 1 on a monthly basis will now only receive it on a weekly basis; and the status of his negotiations with the pharmaceutical companies to bring clarity and hope to these persons. [25237/17]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile